[Anesthetic management of patients with dilated cardiomyopathy undergoing non-cardiac surgery]

Kyung-Ho Chang1, Kazuo Hanaoka

  • 1Department of Anesthesiology, Faculty of Medicine, The University of Tokyo, Tokyo 113-8655.

Masui. the Japanese Journal of Anesthesiology
|February 3, 2005
PubMed

Insights

Anesthetic management for patients with dilated cardiomyopathy (DCM) undergoing non-cardiac surgery requires careful planning. While major complications are infrequent, assessing cardiac reserve is crucial for patient safety.

Area of Science:

  • Cardiology
  • Anesthesiology
  • Cardiomyopathy Research

Context:

  • Limited data exists on cardiac risk in cardiomyopathy patients during non-cardiac surgery.
  • Coronary artery disease data is more abundant but not applicable here.

Purpose:

  • To analyze anesthetic management and outcomes for patients with dilated cardiomyopathy (DCM) undergoing non-cardiac surgery.
  • To identify perioperative risk factors in this patient population.

Summary:

  • A review of 73 patients with DCM undergoing non-cardiac surgery found a mean ejection fraction of 31%, with 70% showing poor ventricular function.
  • Major complications occurred in 6 cases, minor in 23. History of CHF, advanced NYHA class, and lack of preoperative DCM diagnosis were risk factors.
  • Careful anesthetic planning is essential, with cardiac reserve evaluation being more critical than resting ejection fraction.

Impact:

  • Highlights the need for meticulous anesthetic strategies in DCM patients.
  • Suggests that comprehensive cardiac assessment beyond ejection fraction is vital for surgical planning.
  • Underscores the necessity for further research to fully define perioperative risks.
Abstract

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
General Anesthesia: Overview01:24

General Anesthesia: Overview

Anesthesia is a medical procedure that uses drugs for CNS suppression to enable painless surgeries and procedures. The selection of anesthetics is influenced by their pharmacokinetic properties, side effects, and patient characteristics. Various types of anesthesia include general, local, regional, spinal, and inhalational.
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...